Building integrity into your analytical workflow for pharmaceutical development

Integrity in the analytical workflow for pharmaceutical development relies on understanding how both your processes and also the physical characteristics of your materials affect your product’s performance. This starts as early as during the product design phase, by determining how the product delivers patient benefit, and which critical material attributes (CMAs) and critical process parameters (CPPs) will enable you to achieve this.
Different analytical techniques can provide the information you need at different stages of the development process. Fundamental understanding about how components behave and interact relies on detailed material characterization, such as particle size, shape and chemical form. From this, you can progress to determining what physical properties are critical to quality (CTQ) and how it is best to measure and control them during process scale up, through to manufacture.
In this webinar, we will discuss how range of material characterization techniques, including laser diffraction and analytical imaging can help build integrity in your analytical workflow, from discovery right through to QC.